European Coalition on
Homeopathic & Anthroposophic
Medicinal Products

Sitemap

David Reckeweg-Lecompte re-elected as ECHAMP’s President for a second three-year term

ECHAMP is pleased to announce that David Reckeweg-Lecompte has been re-elected as ECHAMP’s President for a second three-year term.

David Reckeweg-Lecompte has been re-elected as ECHAMP’s President for a second three-year term. 

David is embracing his next term of office with enthusiasm. He is as committed as ever to building and developing the sector for homeopathic and anthroposophic medicinal products, in particular in the context of the move towards a stronger EU Health Union and the revision of the General Pharmaceutical Legislation. He explains the importance to the sector of some recent trends in Europe, including the trend towards integrative healthcare, the opportunities and challenges identified in The Green Deal and the drive towards a 'One Health' approach: "Our sector has a significant contribution to make in building an integrated and sustainable future. These important trends open up a world in which the potential of our sector can be better understood and exploited."

David's first term as President was dominated by the pandemic and the practical and commercial challenges it has presented to ECHAMP and its members. He has worked hard to maintain good working relationships at ECHAMP despite the lack of in-person meetings for over two years.  Looking forward to his next term, he says, "We greatly value the good working relationships and collaboration between the companies in our sector and with other organisations in our field. We will continue to work together to realise the potential of this sector and to make sure patients are offered genuine freedom of choice of treatment.” 

Notes for editors

  • David Reckeweg-Lecompte has been a Board member of ECHAMP since 2016; he is Managing Director at Dr. Reckeweg GmbH, Bensheim, Germany, a family business first established nearly 70 years ago, now with distribution in more than 40 countries worldwide. The company offers more than 250 homeopathic products, all manufactured in Bensheim, and is committed to producing high-quality, effective and well-tolerated homeopathic medicines in a sustainable way. David has a background in international finance and business administration and has held his role at Dr. Reckeweg since 2013.

  1. ECHAMP has 40 Full Members from 15 different EU Member States and Norway and four extraordinary partners from Switzerland and UK, all companies involved in the manufacture and distribution of homeopathic and anthroposophic medicinal products (see Map of Members). ECHAMP works to ensure that its members can meet the demand from users and prescribers across the EU for these products.  It advocates for an appropriate regulatory environment in the EU.